Table 2

Clinical outcome for the FLT3WT/WT, FLT3ITD/WT, and FLT3ITD/− genotype groups

FLT3WT/WT (N = 59)FLT3ITD/WT (N = 15)FLT3ITD/− (N = 8)P
Percentage of CR8679750.70
DFS
 Median (months)52a244
 Percentage of DFS at 12 months (95% confidence interval)71 (62, 80)51 (35, 66)17 (12, 22)0.0017
Survival
 Median (months)46a46a7
 Percentage alive at 12 months (95% confidence interval)74 (65, 82)65 (48, 81)13 (10, 15)0.0014
  • a Nonparametric estimate of the median is not available. Tabled value represents the median assuming the survival estimates after the last observation follows an exponential curve.